Peer-Reviewed Papers

Explore published research on mitochondrial function, cellular energy, (-)-epicatechin, vascular biology, and related metabolic pathways. Browse by specialization below to quickly find the papers most relevant to your interests.

Featured Papers

Improving Cardiovascular Risk in Postmenopausal Women with (−)-Epicatechin

Nájera et al., 2024 · Journal of Clinical Medicine

Randomized, double-blind, placebo-controlled proof-of-concept trial evaluating cardiovascular risk–related measures in postmenopausal women using an (−)-epicatechin–enriched cacao supplement.

Antifibrotic Effects of (−)-Epicatechin in High-Glucose–Stimulated Cardiac Fibroblasts

Garate-Carrillo et al., 2021 · Journal of Medicinal Food

Cell-based mechanistic study examining how (−)-epicatechin modulates profibrotic signaling under high-glucose conditions, focusing on GPER and TGF-β1/SMAD pathways.

Modulation of Chronic Renal Damage Markers by (−)-Epicatechin in a 5/6 Nephrectomy Model

Montes-Rivera et al., 2019 · Heliyon

Preclinical study in a progressive chronic kidney disease model assessing the effects of (−)-epicatechin on biomarkers associated with renal injury progression.

Search Papers by Specialization

Epicatechin, Muscle Growth Markers, and Age-Related Muscle Function

Study Title: Effects of (-)-epicatechin on molecular modulators of skeletal muscle growth and differentiation

Citation: Gutierrez-Salmean et al., 2014 · The Journal of Nutritional Biochemistry

What the Study Found: This study examined age-related changes in skeletal muscle growth and differentiation markers in mice and humans, then tested short-term (-)-epicatechin exposure. In aged mice, myostatin and senescence-associated β-galactosidase were higher, while follistatin and Myf5 were lower. (-)-Epicatechin reduced myostatin and β-galactosidase and increased markers associated with muscle growth. In the human proof-of-concept portion, older muscle showed a similar age-related pattern, and seven days of (-)-epicatechin increased hand grip strength and the plasma follistatin-to-myostatin ratio.

What this means in real life: This study supports the idea that aging muscle is affected not only by loss of mass, but also by changes in the signaling environment around muscle growth, differentiation, and cellular senescence. In this early research, (-)-epicatechin was associated with more favorable muscle-related markers and a short-term increase in grip strength. This does not mean (-)-epicatechin treats sarcopenia or reverses muscle aging in humans. It does suggest that muscle resilience and healthy aging may be linked to molecular signals that can be studied and potentially supported.

Clinical Relevance: Mouse and small human proof-of-concept study, aging skeletal muscle, muscle growth and differentiation markers, and short-term (-)-epicatechin exposure.

Related Content:

Oxidative Stress, Inflammation, and Mobility in Older Adults

Study Title: High Flavonoid Cocoa Supplement Ameliorates Plasma Oxidative Stress and Inflammation Levels While Improving Mobility and Quality of Life in Older Subjects: A Double-Blind Randomized Clinical Trial

Citation: Munguia et al., 2019 · The Journals of Gerontology Series A

What the Study Found: In older subjects, daily high-flavonoid cocoa supplementation significantly lowered plasma markers of oxidative stress and inflammation. It also improved objective mobility measures and self-reported quality of life compared with placebo. These benefits occurred without changes in body weight or other basic metabolic parameters.

What this means in real life: As we age, mitochondria produce more oxidative stress and trigger low-grade inflammation, which slowly erodes energy, mobility, and daily vitality. This human trial shows that the (−)-epicatechin and flavanols in cocoa can calm those processes at the systemic level, helping older adults move better and feel better. At Mitozz we focus on mitochondrial health because reducing oxidative burden inside cells is one of the most direct ways to preserve energy and independence as the years go by.

Related Content

Mitochondrial Biogenesis and Oxidative Stress in Aging

Study Title: Recovery of Indicators of Mitochondrial Biogenesis, Oxidative Stress, and Aging With (-)-Epicatechin in Senile Mice

Citation: Moreno-Ulloa et al., 2015 · The Journals of Gerontology: Series A

What the Study Found: In senile (24-month-old) mice, (−)-epicatechin treatment reduced oxidative stress markers and restored indicators of mitochondrial biogenesis to levels seen in young animals. It also improved structural and functional endpoints in multiple tissues. Overall, the flavanol shifted the biology of aged mice toward a more youthful profile.

What this means in real life: Aging naturally erodes mitochondrial biogenesis and raises oxidative stress, draining cellular energy and accelerating decline. This study shows that (−)-epicatechin can reverse these changes in old mice, restoring mitochondrial renewal and lowering oxidative damage. At Mitozz we focus on mitochondrial health because supporting biogenesis and redox balance is one of the most direct ways to promote healthy aging and sustained vitality.

Related Content

Skeletal Muscle Mitochondrial Structure in Type 2 Diabetes and Heart Failure

Study Title: Alterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: effects of epicatechin rich cocoa

Citation: Taub et al., 2012 · Clinical and Translational Science

What the Study Found: Patients with type 2 diabetes and heart failure showed clear impairments in skeletal muscle mitochondrial structure and biogenesis markers compared with healthy controls. Supplementation with epicatechin-rich cocoa restored several of these mitochondrial indicators. The changes were accompanied by improvements in energy-production capacity within muscle cells.

What this means in real life: In type 2 diabetes and heart failure, mitochondria in skeletal muscle become structurally damaged and less able to produce energy, contributing to fatigue and weakness. This study shows that (−)-epicatechin from cocoa can help repair mitochondrial structure and biogenesis markers, directly supporting cellular energy production. At Mitozz we focus on mitochondrial health because restoring this cellular capacity is key to regaining strength and endurance when the heart and metabolism are stressed.

Related Content

Mitochondrial Biogenesis in Muscle Cells via GPER

Study Title: (-)-Epicatechin stimulates mitochondrial biogenesis and cell growth in C2C12 myotubes via the G-protein coupled estrogen receptor

Citation: Moreno-Ulloa et al., 2018 · European Journal of Pharmacology

What the Study Found: In cultured C2C12 myotubes, (−)-epicatechin (3 and 10 µM) increased mitochondrial inner and outer membrane markers, NRF-2, TFAM, and citrate synthase activity. It also promoted myotube growth (longer and wider cells). These effects were largely mediated by the G-protein coupled estrogen receptor (GPER), as shown by receptor blockade and siRNA knockdown.

What this means in real life: Mitochondrial biogenesis in muscle cells is essential for energy production and tissue growth, but it can slow down with age or stress. This study demonstrates that (−)-epicatechin directly stimulates biogenesis and cell growth through the GPER pathway, mimicking some of estrogen’s protective effects on mitochondria. Supporting mitochondrial health helps keep muscle cells energetically robust and responsive to training or daily demands.

Related Content

Triglyceride/HDL Ratio and Cardiometabolic Profile

Study Title: A randomized, placebo-controlled, double-blind study on the effects of (−)-epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects

Citation: Gutiérrez-Salmeán et al., 2016 · International Journal of Cardiology

What the Study Found: In hypertriglyceridemic subjects, 100 mg/day of (−)-epicatechin for 4 weeks significantly improved the triglyceride/HDLc ratio and other cardiometabolic markers. In parallel in vitro experiments, (−)-epicatechin reduced fructose-induced triglyceride accumulation and improved mitochondrial function in liver cells. The effects were superior to those of its stereoisomer (+)-catechin.

What this means in real life: Mitochondria in the liver and muscle are central to balancing fat and sugar metabolism; when they’re stressed, triglycerides rise and HDL falls. This human trial shows that (−)-epicatechin can shift cardiometabolic markers in a favorable direction while directly protecting mitochondrial function in liver cells. Mitochondrial support like this offers a practical way to improve everyday metabolic health and energy efficiency.

Related Content

Apelin Receptor Signaling and Biased Agonism

Study Title: (-)-Epicatechin Is a Biased Ligand of Apelin Receptor

Citation: Portilla-Martínez et al., 2022 · International Journal of Molecular Sciences

What the Study Found: Using molecular dynamics simulations and in vitro assays, researchers showed that (−)-epicatechin acts as a biased ligand of the apelin receptor (APLN). It preferentially recruits β-arrestin in its active conformation while modulating downstream signaling pathways. This biased agonism was distinct from unbiased apelin signaling.

What this means in real life: The apelin receptor helps regulate energy metabolism, vascular tone, and mitochondrial function in heart and muscle cells. This study reveals that (−)-epicatechin can selectively activate beneficial branches of this pathway, supporting cellular energy balance without overstimulating other signals. At Mitozz we focus on mitochondrial health because compounds like (−)-epicatechin that fine-tune energy-related receptors help cells maintain efficient energy production and resilience.

Related Content

eNOS Activation and Nitric Oxide Signaling Pathways

Study Title: (-)-epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways

Citation: Ramirez-Sanchez et al., 2010 · Hypertension

What the Study Found: (−)-Epicatechin activated endothelial nitric oxide synthase (eNOS) in human coronary artery cells through specific phosphorylation (Ser633 and Ser1177) and dephosphorylation (Thr495) events. It worked via the PI3K pathway, Ca²⁺/CaMKII signaling, and cell-surface mechanisms. The result was increased nitric oxide production and improved vascular signaling.

What this means in real life: Mitochondria in endothelial cells supply the energy for nitric oxide production, which keeps arteries flexible and blood pressure healthy. This study shows that (−)-epicatechin rapidly activates eNOS through well-defined signaling routes, enhancing nitric oxide output. Supporting mitochondrial health ensures these energy-dependent pathways stay responsive, helping your vascular system function at its best.

Related Content

GPER Receptor and Endothelial Nitric Oxide Production

Study Title: The effects of (−)-epicatechin on endothelial cells involve the G protein-coupled estrogen receptor (GPER)

Citation: Moreno-Ulloa et al., 2015 · Pharmacol Res

What the Study Found: (−)-Epicatechin binds to the G protein-coupled estrogen receptor (GPER) on endothelial cells and activates downstream signaling (ERK 1/2 and CaMKII) via the GPER/c-SRC/EGFR axis. This pathway stimulates nitric oxide production and causes vasodilation in aortic rings. The effects mimic those of a known GPER agonist.

What this means in real life: Endothelial mitochondria need fast, accurate signals to produce nitric oxide and keep blood vessels relaxed. This study reveals that (−)-epicatechin works through a specific surface receptor (GPER) to trigger those signals, boosting nitric oxide without entering the cell. Mitochondrial support helps keep this energy-dependent vascular communication running smoothly for better circulation and heart health.

Related Content

Preeclampsia, Arginase, and Endothelial Protection

Study Title: Influence of the AT(2) receptor on the L-arginine-nitric oxide pathway and effects of (-)-epicatechin on HUVECs from women with preeclampsia

Citation: Olivares-Corichi et al., 2013 · J Hum Hypertens

What the Study Found: Endothelial cells from women with preeclampsia showed lower nitric oxide levels, higher arginase activity, and increased oxidative stress compared with normal pregnancy. (−)-Epicatechin reduced both arginase and NADPH oxidase activity in these cells. The changes helped restore nitric oxide production balance.

What this means in real life: Mitochondria in blood-vessel cells power nitric oxide production; when arginase and oxidative stress rise, energy efficiency drops and vessels suffer. This study shows that (−)-epicatechin can calm these pathways even in challenging conditions like preeclampsia, protecting endothelial mitochondrial function. Supporting mitochondrial health helps maintain healthy blood-flow signaling when the cardiovascular system is under stress.

Related Content

Postprandial Fat Oxidation and Epicatechin

Study Title: Acute effects of an oral supplement of (-)-epicatechin on postprandial fat and carbohydrate metabolism in normal and overweight subjects

Citation: Gutiérrez-Salmeán et al., 2014 · Food & Function

What the Study Found: A single oral dose of (−)-epicatechin increased postprandial lipid catabolism, shown by a lower respiratory quotient indicating greater fat oxidation. It also lowered postprandial plasma glucose and triglyceride levels, with stronger effects in overweight subjects. These metabolic shifts occurred rapidly after the supplement.

What this means in real life: After meals, mitochondria must quickly switch between burning carbs and fats; when they’re less efficient, blood sugar and fats stay elevated longer. This study shows that (−)-epicatechin can shift the body toward greater fat oxidation right after eating, helping mitochondria handle mixed meals more effectively. Mitochondrial support like this is a simple way to improve everyday metabolic flexibility and energy stability.

Related Content

Flavanol Nutraceuticals and Nonalcoholic Liver Disease

Study Title: Is it possible to treat nonalcoholic liver disease using a flavanol-based nutraceutical approach? Basic and clinical data

Citation: Hidalgo et al., 2022 · Journal of Basic and Clinical Physiology and Pharmacology

What the Study Found: This review examined whether flavanol-based nutraceutical approaches, especially epigallocatechin-3-gallate and (-)-epicatechin, may be relevant to nonalcoholic fatty liver disease biology. The authors discussed how NAFLD is linked to obesity, insulin resistance, gut microbiota changes, low-grade inflammation, nitroxidative stress, lipid peroxidation, and mitochondrial dysfunction. They summarized preclinical and limited clinical evidence suggesting that flavanols may influence liver lipid metabolism, inflammatory signaling, antioxidant defenses, mitochondrial biogenesis, nitric oxide signaling, and pathways involved in hepatic fat accumulation.

What this means in real life: This paper is useful because it connects liver fat biology to the same systems that often appear in mitochondrial health discussions: energy metabolism, oxidative balance, inflammation, and lipid handling. The review suggests that (-)-epicatechin has several biological properties worth studying in NAFLD models. This does not mean (-)-epicatechin treats NAFLD, NASH, or liver disease in humans. The practical takeaway is that metabolic liver health is closely tied to mitochondrial function and cellular stress regulation.

Clinical Relevance: Review article, focused on flavanols, NAFLD biology, lipid metabolism, oxidative stress, inflammation, mitochondrial dysfunction, and limited clinical evidence.

Related Content:

Continue Exploring Mitochondrial Science